A large group of organizations are calling on Congress to remove regulatory barriers in order to allow generic drug makers to have access to brand name drugs for FDA testing and approval.  The bill would encourage competitive entry once brand name drug patents have expired, permitting new rivals to provide lower cost drugs to doctors and patients.  Proposal like the Creates are pro-consumer, because they encourage price competition, which saves patients, hospitals and insurers money, as well as providing affordable access to medications.

You can read the letter here.